UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

Journal of clinical oncology, 2006-05, Vol.24 (13), p.2038-2043

2006

Volltextzugriff (PDF)

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Journal of clinical oncology, 2003-11, Vol.21 (22), p.4112-4119

2003

Volltextzugriff (PDF)

Size-related heterogeneity of colorectal liver metastases (CRLM) in patients with advanced RAS wild-type metastatic colorectal cancer (mCRC) treated in the PanaMa trial: Implication for treatment decisions

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3553-3553

2023

Volltextzugriff (PDF)

Impact of number and size of colorectal metastases (CRM) on survival in patients with RAS wild-type metastatic colorectal cancer treated within the PanaMa trial (AIO KRK 0212)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3551-3551

2023

Volltextzugriff (PDF)

Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic CRC: Analysis of patients treated within the PanaMa trial (AIO KRK 0212)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.127-127

2023

Volltextzugriff (PDF)

Epidemiological and demographic characteristics of gynecological sarcoma: Results of the prospective intergroup registry for gynecological sarcoma in Germany (REGSA–NOGGO RU1)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17630-e17630

2022

Volltextzugriff (PDF)

Endosonography With or Without Confirmatory Mediastinoscopy for Resectable Lung Cancer: A Randomized Clinical Trial

Journal of clinical oncology, 2023-08, Vol.41 (22), p.3805-3815

2023

Volltextzugriff (PDF)

Linking dispositional mindfulness and positive psychological processes in cancer survivorship: A multivariate path analysis

Journal of clinical oncology, 2014-11, Vol.32 (31_suppl), p.237-237

2014

Volltextzugriff (PDF)

A qualitative investigation of mindfulness practice to support advance care planning (ACP)

Journal of clinical oncology, 2016-10, Vol.34 (26_suppl), p.15-15

2016

Volltextzugriff (PDF)

Breast cancer and overall mortality following a diagnosis of ductal carcinoma in situ (DCIS) at major community cancer center: A report of 1,014 cases

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e12015-e12015

2016

Volltextzugriff (PDF)

Effects of mindfulness meditation on quality of life in adults with advanced cancer and family caregivers: A randomized pilot

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.10096-10096

2018

Volltextzugriff (PDF)

Impact of mindfulness training on avoidant coping and advance care planning

Journal of clinical oncology, 2014-11, Vol.32 (31_suppl), p.86-86

2014

Volltextzugriff (PDF)

Urgent versus elective inpatient anticancer therapy in patients with metastatic solid tumors: Analysis of admission characteristics and posthospitalization clinical outcomes

Journal of clinical oncology, 2017-11, Vol.35 (31_suppl), p.12-12

2017

Volltextzugriff (PDF)

Cognitive technology addressing optimal cancer clinical trial matching and protocol feasibility in a community cancer practice

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6501-6501

2017

Volltextzugriff (PDF)

Implementing Lynch syndrome screening utilizing a community partnership

Journal of clinical oncology, 2013-11, Vol.31 (31_suppl), p.203-203

2013

Volltextzugriff (PDF)

A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer

Journal of clinical oncology, 2016-06, Vol.34 (18_suppl), p.LBA1-LBA1

2016

Volltextzugriff (PDF)

A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.LBA1-LBA1

2016

Volltextzugriff (PDF)

The signature program, a series of tissue-agnostic, mutation-specific signal finding trials

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS2646-TPS2646

2014

Volltextzugriff (PDF)

A phase Ib study of abemaciclib with therapies for metastatic breast cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.522-522

2015

Volltextzugriff (PDF)

Genomic mutation profiling (GMP) and clinical outcome of patients treated with buparlisib (PI3K inhibitor) in the “Signature” program

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2516-2516

2015

Volltextzugriff (PDF)

Presence of carcinoma in situ (CIS) in bladder cancer biopsies and its relationship to pathologic complete response (pCR) rates to neoadjuvant chemotherapy (neo-CTx)

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.286-286

2013

Volltextzugriff (PDF)

Presence of variant histology (VarHst) in transurethral resection of bladder tumor (TURBT) biopsies and its prognostic significance on pathologic complete response (pCR) rates to neoadjuvant chemotherapy (neo-CTx)

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.295-295

2013

Volltextzugriff (PDF)

Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting

Journal of clinical oncology, 1992-12, Vol.10 (12), p.1969-1975

1992

Volltextzugriff (PDF)

Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2117-2122

1995

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieConsulting-Specifying Engineer

ThemaAnimals

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(2)

Erscheinungsjahr

n.n

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Size-related heterogeneity of colorectal liver metastases (CRLM) in patients with advanced RAS wild-type metastatic colorectal cancer (mCRC) treated in the PanaMa trial: Implication for treatment decisions

Impact of number and size of colorectal metastases (CRM) on survival in patients with RAS wild-type metastatic colorectal cancer treated within the PanaMa trial (AIO KRK 0212)

Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic CRC: Analysis of patients treated within the PanaMa trial (AIO KRK 0212)

Epidemiological and demographic characteristics of gynecological sarcoma: Results of the prospective intergroup registry for gynecological sarcoma in Germany (REGSA–NOGGO RU1)

Endosonography With or Without Confirmatory Mediastinoscopy for Resectable Lung Cancer: A Randomized Clinical Trial

Linking dispositional mindfulness and positive psychological processes in cancer survivorship: A multivariate path analysis

A qualitative investigation of mindfulness practice to support advance care planning (ACP)

Breast cancer and overall mortality following a diagnosis of ductal carcinoma in situ (DCIS) at major community cancer center: A report of 1,014 cases

Effects of mindfulness meditation on quality of life in adults with advanced cancer and family caregivers: A randomized pilot

Impact of mindfulness training on avoidant coping and advance care planning

Urgent versus elective inpatient anticancer therapy in patients with metastatic solid tumors: Analysis of admission characteristics and posthospitalization clinical outcomes

Cognitive technology addressing optimal cancer clinical trial matching and protocol feasibility in a community cancer practice

Implementing Lynch syndrome screening utilizing a community partnership

A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer

A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer

The signature program, a series of tissue-agnostic, mutation-specific signal finding trials

A phase Ib study of abemaciclib with therapies for metastatic breast cancer

Genomic mutation profiling (GMP) and clinical outcome of patients treated with buparlisib (PI3K inhibitor) in the “Signature” program

Presence of carcinoma in situ (CIS) in bladder cancer biopsies and its relationship to pathologic complete response (pCR) rates to neoadjuvant chemotherapy (neo-CTx)

Presence of variant histology (VarHst) in transurethral resection of bladder tumor (TURBT) biopsies and its prognostic significance on pathologic complete response (pCR) rates to neoadjuvant chemotherapy (neo-CTx)

Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting

Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen

Aktive Filter

Suchergebnisse filtern